# Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan

> **NCT02606357** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 242 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** INSULIN GLARGINE

## Key facts

- **NCT ID:** NCT02606357
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-22
- **Primary completion:** 2017-11-27
- **Final completion:** 2017-11-27
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2018-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02606357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02606357, "Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02606357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*